Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
All-trans retinoic acid and protein kinase C α/β1 inhibitor combined treatment targets cancer stem cells and impairs breast tumor progression.
Berardi DE, Ariza Bareño L, Amigo N, Cañonero L, Pelagatti MLN, Motter AN, Taruselli MA, Díaz Bessone MI, Cirigliano SM, Edelstein A, Peters MG, Diament M, Urtreger AJ, Todaro LB. Berardi DE, et al. Among authors: amigo n. Sci Rep. 2021 Mar 15;11(1):6044. doi: 10.1038/s41598-021-85344-w. Sci Rep. 2021. PMID: 33723318 Free PMC article.
Antineoplastic activity of products derived from cellulose-containing materials: levoglucosenone and structurally-related derivatives as new alternatives for breast cancer treatment.
Delbart DI, Giri GF, Cammarata A, Pan MD, Bareño LA, Amigo NL, Bechis A, Suarez AG, Spanevello RÁ, Villaverde MS, Todaro LB, Urtreger AJ. Delbart DI, et al. Invest New Drugs. 2022 Feb;40(1):30-41. doi: 10.1007/s10637-021-01167-6. Epub 2021 Sep 3. Invest New Drugs. 2022. PMID: 34478029
Author Correction: Antineoplastic activity of products derived from cellulose‑containing materials: levoglucosenone and structurally‑related derivatives as new alternatives for breast cancer treatment.
Delbart DI, Giri GF, Cammarata A, Pan MD, Bareño LA, Amigo NL, Bechis A, Suarez AG, Spanevello RÁ, Villaverde MS, Todaro LB, Urtreger AJ. Delbart DI, et al. Invest New Drugs. 2022 Feb;40(1):42. doi: 10.1007/s10637-021-01200-8. Invest New Drugs. 2022. PMID: 34843006 No abstract available.
114 results